載入...
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
The novel coronavirus infection (COVID-19) is caused by the new coronavirus SARS-CoV-2 and is characterized by an exaggerated inflammatory response that can lead to severe manifestations such as adult respiratory syndrome, sepsis, coagulopathy, and death in a proportion of patients. Among other fact...
Na minha lista:
| 發表在: | Clin Appl Thromb Hemost |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7370334/ https://ncbi.nlm.nih.gov/pubmed/32677459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029620938149 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|